VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Vireo Growth Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$9.01+0.01 (+0.11%)
Close on Oct 19, 2026
- Market cap
- $406.23M
- P/E (TTM)
- –
- Dividend yield
- –
Vireo Growth statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Vireo Growth | Industry median |
|---|---|---|
| Market Cap | $433.00M | $166.30M |
| Enterprise Value | $328.90M | $88.19M |
| PS Ratio | 0.85 | 3.65 |
| PB Ratio | 0.98 | 2.03 |
| P/TBV Ratio | 6.91 | 2.29 |
| P/OCF Ratio | 16.52 | 12.98 |
Enterprise value
| Measure | Vireo Growth | Industry median |
|---|---|---|
| EV / Sales | 0.64 | 2.51 |
| EV / EBITDA | 12.75 | 14.65 |
| EV / EBIT | 194.09 | 19.00 |
Income (trailing twelve months)
| Measure | Vireo Growth | Industry median |
|---|---|---|
| Revenue | $511.67M | $58.34M |
| Gross Profit | $248.87M | $105.94M |
| Operating Income | $1.69M | -$21.40M |
| Pretax Income | -$15.00M | -$14.34M |
| Net Income | -$67.07M | -$22.46M |
| EBITDA | $25.80M | -$16.91M |
| EPS (Diluted) | -$2.08 | -$0.83 |
Margins
| Measure | Vireo Growth | Industry median |
|---|---|---|
| Gross Margin | 48.6% | 52.9% |
| Operating Margin | 0.33% | -44.0% |
| Pretax Margin | -2.93% | -13.3% |
| Profit Margin | -13.1% | -40.2% |
| EBITDA Margin | 5.04% | -30.2% |
| FCF Margin | -22.7% | -9.27% |
Returns
| Measure | Vireo Growth | Industry median |
|---|---|---|
| Return on Equity (ROE) | -18.9% | -53.2% |
| Return on Assets (ROA) | -6.94% | -40.9% |
| Return on Invested Capital (ROIC) | 0.54% | -32.4% |
| Return on Capital Employed (ROCE) | 0.19% | -38.1% |
Growth
| Measure | Vireo Growth | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 316.7% | 5.96% |
| Revenue Growth (3Y CAGR) | 53.3% | 2.25% |
| Revenue Growth (5Y CAGR) | 40.4% | 6.48% |
Balance sheet
| Measure | Vireo Growth | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $104.10M | $61.43M |
| Net Cash (Debt) | $104.10M | $15.35M |
| Net Cash Per Share | $2.17 | $0.66 |
| Equity (Book Value) | $442.50M | $49.09M |
| Book Value Per Share | $9.21 | $1.37 |
| Tangible Book Value | $62.70M | $23.52M |
| Working Capital | $3.80M | $76.81M |
Financial position
| Measure | Vireo Growth | Industry median |
|---|---|---|
| Current Ratio | 1.01 | 3.34 |
| Quick Ratio | 0.27 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Vireo Growth | Industry median |
|---|---|---|
| Operating Cash Flow | $26.21M | -$12.35M |
| Capital Expenditures | -$142.52M | -$1.08M |
| Free Cash Flow | -$116.31M | -$20.22M |
| FCF Per Share | -$2.42 | -$0.42 |
Efficiency
| Measure | Vireo Growth | Industry median |
|---|---|---|
| Asset Turnover | 0.53 | 0.39 |
| Inventory Turnover | 2.47 | 2.70 |
| Revenue Per Employee | $836.06K | $404.87K |
| Profits Per Employee | -$109.59K | -$703.34K |
| Employee Count | 612 | 74 |
Dividends and yields
| Measure | Vireo Growth | Industry median |
|---|---|---|
| Earnings Yield | -15.5% | -23.3% |
| FCF Yield | -26.9% | -8.72% |
Shares
| Measure | Vireo Growth | Industry median |
|---|---|---|
| Shares Outstanding | 48,057,300 | 58,127,000 |
| Shares Change (YoY) | 226.3% | 10.9% |
Scores
| Measure | Vireo Growth | Industry median |
|---|---|---|
| Altman Z-Score | 0.37 | -0.22 |
| Piotroski F-Score | 4 | 4 |
| Beneish M-Score | 1.53 | -2.62 |
Calculated by StockData from Vireo Growth's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.